Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals - Report - MDSpire

Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals

  • By

  • Jiazi Tian

  • Alaleh Azhir

  • Matthew Decaro

  • Ngan Chau

  • Jonas Hügel

  • Michele Morris

  • Jingya Cheng

  • Pedram Fard

  • Ingrid V. Bassett

  • Douglas S. Bell

  • Elmer V. Bernstam

  • Shyam Visweswaran

  • Jeffrey G. Klann

  • Shawn N. Murphy

  • Hossein Estiri

  • May 27, 2026

  • 0 min

Share

Clinical Report: Enduring Long COVID and Surveillance Deficiencies in 58 Hospitals

Overview

Revise to emphasize the clinical implications of the discrepancies in prevalence estimates.

Background

Postacute sequelae of SARS-CoV-2 infection (PASC) presents a growing public health challenge, with estimates suggesting that a substantial proportion of COVID-19 survivors experience long-term symptoms. Accurate surveillance and understanding of PASC are critical for effective healthcare planning and resource allocation, especially as these conditions may require ongoing clinical management.

Data Highlights

No numerical data available in the source material.

Key Findings

Rephrase findings for clarity and ensure they are directly supported by the source.

Clinical Implications

Healthcare providers should be aware of the limitations of administrative coding in capturing the true burden of PASC. Enhanced surveillance methods, such as the P2RC algorithm, may improve identification and management of patients with long COVID, ensuring they receive appropriate care.

Conclusion

The study emphasizes the need for improved surveillance and clinical management strategies for PASC, highlighting the chronic nature of the condition and its implications for healthcare systems.

Related Resources & Content

  1. The Journal of Infectious Diseases, 2023 -- The Current and Future Burden of Long COVID in the United States
  2. Open Forum Infectious Diseases, 2023 -- Association of Viral Load and Disease Severity in Acute SARS-CoV-2 Infection with the Development of Long COVID Symptoms
  3. Open Forum Infectious Diseases, 2023 -- Impact of SARS-CoV-2 on Health-Related Quality of Life One Year Post-Infection: A Latent Transition Analysis
  4. Long COVID Clinical Guidance | Long COVID | CDC, 2026
  5. Open Forum Infectious Diseases — Health-Related Quality of Life Outcomes Two Years Post Mild to Moderate SARS-CoV-2 Infection During the Pre-Omicron Period
  6. Long COVID Clinical Guidance | Long COVID | CDC
  7. Nirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial - ScienceDirect
  8. Coding long COVID: characterizing a new disease through an ICD-10 lens | BMC Medicine | Full Text

Original Source(s)

Related Content